ANGPTL8 and coronary artery disorder: ANGPTL8 presents a negative effect on HDL-mediated cholesterol efflux capacity [17] and a strong link with subclinical atherosclerosis [27], and its levels are significantly increased in patients with coronary disease, proportional to disease severity [45].